文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

荷兰全国早产儿视网膜病变筛查现状调查

Nationwide inventory on retinopathy of prematurity screening in the Netherlands.
PubMed 文献 · Br J Ophthalmol · 2021-12-10

该多中心前瞻性全国研究纳入2017年荷兰所有符合早产儿视网膜病变(ROP)筛查条件的早产儿,比较2009年首次全国筛查调查(NEDROP-1)数据。结果显示ROP总体发生率保持稳定,但严重ROP数量近乎翻倍;筛查婴儿数减少近三分之一,显示新筛查标准实施良好;视网膜脱离明显减少,提示治疗结局改善。

要点

  • 2017年筛查婴儿数较2009年校正后减少28.4%(479/1688),显示新筛查标准实施良好。
  • 存活且胎龄<32周婴儿中ROP发生率为20.4%(305/1492),严重ROP(≥3期)为3.3%(49/1492)。
  • ROP≥3期婴儿中进展为视网膜脱离者为6.1%(3/49),较2009年的20.0%(6/30)明显下降。

核心结论

  • ROP总体发生率以百分比表示保持稳定,但发生严重ROP的婴儿数近乎翻倍。
  • 筛查婴儿数减少近三分之一,显示新筛查标准实施良好。
  • 视网膜脱离明显减少,勾勒出治疗结局的改善。

研究设计与样本

  • 多中心前瞻性全国研究,纳入2017年在荷兰出生且符合ROP筛查条件的所有早产儿。
  • 合并眼科医生与儿科医生的匿名数据,并与2009年首次全国ROP调查(NEDROP-1)进行比较。

主要发现

  • 2017年胎龄<32周活产婴儿1492例(2009年1662例),符合筛查条件者1287例(2009年2033例)。
  • 眼科医生实际筛查1085例(2009年1688例),按活产数差异校正系数1.114后,筛查婴儿数减少28.4%(479/1688)。
  • 存活且胎龄<32周婴儿中,ROP见于305/1492例(20.4%);2009年为324/1662例(19.5%)。
  • ROP≥3期见于49/1492例(3.3%);2009年为30/1662例(1.8%)。
  • 所有婴儿均按ETROP标准报告有无附加病变;39例接受了治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Provide up-to-date insight in incidence of retinopathy of prematurity (ROP), logistics of screening and treatment in the Netherlands and influence of the new national ROP guideline in which more stringent screening criteria were implemented and the early treatment for ROP criteria (ETROP) were emphasised. METHODS: Multicentre prospective nationwide study including all preterm infants, born in the Netherlands in 2017, and considered eligible for ROP screening. Anonymised data from ophthalmologists and paediatricians were merged. Outcome data were compared with the first national ROP inventory (NEDROP-1, 2009). RESULTS: In 2017, 1492 infants were live born with gestational age (GA) <32 weeks (2009: 1662); 1287 infants were eligible for screening (2009: 2033). Ophthalmologists screened 1085 infants, versus 1688 in 2009, corrected with factor 1.114 for the difference in number of live births, a 28.4% (479/1688) decrease in screened infants was seen. Among surviving infants with GA <32 week, ROP was found in 305/1492 babies, 20.4% (2009: 324/1662, 19.5%) of which 49/1492 stage ≥3, 3.3% (2009: 30/1662, 1.8%). In all infants, report on presence or absence of plus disease was provided, according to the ETROP criteria. Treatment was performed in 39 infants. Of infants with ROP stage ≥3, 3/49 (6.1%) progressed to retinal detachment (2009: 6/30, 20.0%). CONCLUSION: The overall ROP incidence expressed as a percentage, remained stable but the number of infants that developed severe ROP nearly doubled. A near one-third reduction in screened infants shows satisfactory implementation of the new screening criteria. A notable decrease in retinal detachment delineates improved treatment outcome.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Trzcionkowska K, Termote JU, Böhringer S, et al. Nationwide inventory on retinopathy of prematurity screening in the Netherlands. Br J Ophthalmol. 2021. PMID: 34893474. doi:10.1136/bjophthalmol-2021-319929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。